Pfizer Inc (PFE)
39.90
-0.32 (-0.80%)
USD |
NYSE |
Mar 28, 14:15
Pfizer Market Cap: 224.20B for March 28, 2023
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| March 27, 2023 | 226.00B |
| March 24, 2023 | 226.95B |
| March 23, 2023 | 225.77B |
| March 22, 2023 | 224.82B |
| March 21, 2023 | 228.47B |
| March 20, 2023 | 229.31B |
| March 17, 2023 | 225.32B |
| March 16, 2023 | 226.84B |
| March 15, 2023 | 226.34B |
| March 14, 2023 | 224.20B |
| March 13, 2023 | 223.98B |
| March 10, 2023 | 221.34B |
| March 09, 2023 | 221.73B |
| March 08, 2023 | 225.44B |
| March 07, 2023 | 226.67B |
| March 06, 2023 | 231.00B |
| March 03, 2023 | 231.22B |
| March 02, 2023 | 228.25B |
| March 01, 2023 | 225.77B |
| February 28, 2023 | 227.97B |
| February 27, 2023 | 229.15B |
| February 24, 2023 | 234.60B |
| February 23, 2023 | 237.69B |
| February 22, 2023 | 238.14B |
| February 21, 2023 | 239.93B |
| Date | Value |
|---|---|
| February 17, 2023 | 242.67B |
| February 16, 2023 | 241.21B |
| February 15, 2023 | 243.29B |
| February 14, 2023 | 245.53B |
| February 13, 2023 | 247.05B |
| February 10, 2023 | 246.43B |
| February 09, 2023 | 243.40B |
| February 08, 2023 | 246.99B |
| February 07, 2023 | 244.80B |
| February 06, 2023 | 245.76B |
| February 03, 2023 | 247.44B |
| February 02, 2023 | 249.01B |
| February 01, 2023 | 246.94B |
| January 31, 2023 | 248.00B |
| January 30, 2023 | 244.58B |
| January 27, 2023 | 245.92B |
| January 26, 2023 | 248.51B |
| January 25, 2023 | 253.11B |
| January 24, 2023 | 251.09B |
| January 23, 2023 | 252.61B |
| January 20, 2023 | 253.34B |
| January 19, 2023 | 252.50B |
| January 18, 2023 | 252.72B |
| January 17, 2023 | 258.79B |
| January 13, 2023 | 268.73B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
149.73B
Minimum
Mar 23 2020
343.79B
Maximum
Dec 16 2021
229.44B
Average
223.48B
Median
May 04 2021
Market Cap Benchmarks
| Moderna Inc | 56.67B |
| Amgen Inc | 126.89B |
| Gilead Sciences Inc | 100.73B |
| Johnson & Johnson | 396.84B |
| Eli Lilly and Co | 319.96B |
Market Cap Related Metrics
| PE Ratio | 7.281 |
| PS Ratio | 2.280 |
| PEG Ratio | 0.1720 |
| Price to Book Value | 2.344 |
| Price to Free Cash Flow | 8.788 |
| Price | 39.90 |
| Earnings Yield | 13.73% |
| PEGY Ratio | 0.1571 |
| Operating PE Ratio | 6.137 |
| Normalized PE Ratio | 6.513 |